Kevin F McLaughlin sold $389K of Vericel (VCEL)

Executed Nov 13 2024, disclosed Nov 15 2024, 2 days later.

Value, as filed

$389K

7,000 sh × $55.54

Executed

Nov 13 2024

the trade date, as filed

Disclosed

Nov 15 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Kevin F McLaughlin Director profile →

Kevin F McLaughlin (Director) filed 5 Form 4 reports in the trailing twelve months (1 purchase, 4 sales), most often in Vericel Corporation (VCEL). Across 1 priced purchase filing, the average 21-session return was -9.8% from execution and -10.5% from disclosure (delay-adjusted; derived). The largest single filing was $312K of VCEL (7,000 sh × $44.53, as filed), executed Aug 12.

The name

VCEL

Vericel Corporation VCEL · Healthcare · 47 filings in 24 months ticker →

Healthcare · Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of c…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Kevin F McLaughlin in VCEL

VCELSALE Vericel Corporation $312K
7,000 sh × $44.53
Exec Aug 12
Filed Aug 14 · 4:05 PM ET VCELSALE Vericel Corporation $230K
7,000 sh across 2 lots
Exec May 13
Filed May 15 · 5:30 PM ET VCELSALE Vericel Corporation $243K
7,000 sh × $34.66
Exec Feb 11
Filed Feb 13 · 5:30 PM ET VCELSALE Vericel Corporation $270K
7,000 sh × $38.59
Exec Nov 10 2025
Filed Nov 12 2025 · 5:30 PM ET VCELSALE Vericel Corporation $251K
7,000 sh × $35.92
Exec Aug 6 2025
Filed Aug 8 2025 · 5:30 PM ET VCELSALE Vericel Corporation $280K
7,000 sh × $39.98
Exec May 7 2025
Filed May 9 2025 · 5:30 PM ET VCELSALE Vericel Corporation $333K
6,000 sh × $55.47
Exec Feb 12 2025
Filed Feb 14 2025 · 5:30 PM ET